Immunization

Latest Issue of OR Manager
February 2022
Home Personnel > Personnel > Immunization

Association of allergy history with allergic reactions in HCWs after COVID-19 vaccinations

Editor's Note This study by researchers at Harvard Medical School, Brigham and Women’s Hospital, and Massachusetts General Hospital, Boston, finds that a high-risk allergy history was associated with a 2.5-fold higher risk of allergic reactions after mRNA COVID-19 vaccinations. However, most of the allergy symptoms did not hold up completion…

Read More

By: Judy Mathias
October 26, 2021
Share

CDC expands eligibility for COVID-19 boosters

Editor's Note The Centers for Disease Control and Prevention (CDC) director Rochelle P. Walensky, MD, MPH, on October 21, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation for a booster of COVID-19 vaccines in certain populations. For individuals who received Pfizer-BioNTech or Moderna COVID-19 vaccines, the following are eligible…

Read More

By: Judy Mathias
October 26, 2021
Share

COVID-19 breakthrough infections in HCWs vaccinated with the Pfizer-BioNTech vaccine

  Editor's Note This Israeli study finds that in healthcare workers (HCWs) vaccinated with the Pfizer-BioNTech vaccine who had breakthrough infections, the suspected source was an unvaccinated person. Among 11,453 fully vaccinated HCWs, 1,497 had RT-PCR testing during the study period. Of the tested HCWs, 39 breakthrough cases were found.…

Read More

By: Judy Mathias
October 25, 2021
Share

Sponsored Message

COVID-19 vaccine acceptance, access among Blacks, Latinxs

Editor's Note This study by researchers at Yale University School of Medicine, New Haven, Connecticut, identifies three themes centered on trust and addressing barriers to COVID-19 vaccine access in Black and Latinx communities in the US. The study involved 72 participants—56 women, 16 men, 36 Black, 28 Latinx, and 8…

Read More

By: Judy Mathias
October 14, 2021
Share

CDC: Safety monitoring of COVID-19 vaccine booster dose

Editor's Note This study by researchers at the Centers for Disease Control and Prevention finds that adverse reactions after the third dose of Pfizer-BioNTech’s COVID-19 vaccine were similar to those after the second dose. Of 12,591 participants who completed a survey after all three doses: 79.4% and 74.1% reported local…

Read More

By: Judy Mathias
October 1, 2021
Share

FDA authorizes Pfizer-BioNTech COVID-19 vaccine boosters for certain populations

Editor's Note The Food and Drug Administration (FDA) on September 22 amended the emergency use authorization (EUA) for Pfizer-BioNTech’s COVID-19 vaccine to allow for use of a single booster to be administered at least 6 months after completion of the primary series in those: 65 years of age and older…

Read More

By: Judy Mathias
September 23, 2021
Share

Sponsored Message

CDC: COVID-19 vaccine efficacy for preventing hospitalization

Editor's Note In this study, Centers for Disease Control and Prevention (CDC) researchers report on the comparative effectiveness of COVID-19 vaccines against hospitalization of US adults without immunocompromised conditions. Included in the case-control analysis were 3,689 adults aged 18 years and older who were hospitalized at 21 US hospitals between…

Read More

By: Judy Mathias
September 20, 2021
Share

FDA committee votes against COVID-19 vaccine boosters for general population

Editor's Note The Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee on September 17 voted that there was not enough safety and effectiveness data to approve a third Pfizer COVID-19 vaccine dose for those 16 years and older. The committee did vote to recommend approval of…

Read More

By: Judy Mathias
September 20, 2021
Share

CDC: COVID-19 transmission is high in more than 95% of US counties

Editor's Note A total of 95.19% of US counties are reporting high COVID-19 transmission rates, with at least 100 new cases per 100,000 people in the past 7 days, according to the Centers for Disease Control and Prevention. The surge in COVID-19 cases is being driven largely by the Delta…

Read More

By: Judy Mathias
September 9, 2021
Share

ANA urges HHS to declare nurse staffing shortage a national crisis

Editor's Note The American Nurses Association (ANA) on September 1 wrote a letter to the Department of Health and Human Services (HHS), urging the agency to declare the ongoing shortage of nurses in the US a national crisis, citing the spread of the COVID-19 Delta variant as a factor. In…

Read More

By: Judy Mathias
September 8, 2021
Share

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
February 2022
Video Spotlight
Live chat by BoldChat